AMCYTE INC has a total of 15 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are LIFE SCIENCE INST INC, PRIMEGEN BIOTECH LLC and ANTEROGEN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Tsang Wen-Ghih | 14 |
#2 | Zheng Tianli | 12 |
#3 | Huang Chang Jiang | 5 |
#4 | Wang Yanping | 5 |
#5 | Liu Wei | 3 |
#6 | Florio Monica | 1 |
#7 | Tianli Zheng | 1 |
#8 | Wen-Ghih Tsang | 1 |
#9 | Tu Yiping | 1 |
#10 | Chen Hong-Jung | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007084730A2 | Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture | |
US2007015279A1 | Methods of Selecting Pancreatic Endocrine Cells Using Protein Synthesis Inhibitors | |
AU2003268534A8 | Cd56 positive human adult pancreatic endocrine progenitor cells | |
US2003170215A1 | In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development | |
US6759039B2 | Culturing pancreatic stem cells having a specified, intermediate stage of development |